PEPCID PRESERVATIVE FREE Drug Patent Profile
✉ Email this page to a colleague
When do Pepcid Preservative Free patents expire, and when can generic versions of Pepcid Preservative Free launch?
Pepcid Preservative Free is a drug marketed by Merck and Merck Sharp Dohme and is included in two NDAs.
The generic ingredient in PEPCID PRESERVATIVE FREE is famotidine. There are eighteen drug master file entries for this compound. One hundred and thirty-seven suppliers are listed for this compound. Additional details are available on the famotidine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Pepcid Preservative Free
A generic version of PEPCID PRESERVATIVE FREE was approved as famotidine by FRESENIUS KABI USA on April 16th, 2001.
Summary for PEPCID PRESERVATIVE FREE
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 10 |
| Patent Applications: | 6,449 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | PEPCID PRESERVATIVE FREE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for PEPCID PRESERVATIVE FREE
US Patents and Regulatory Information for PEPCID PRESERVATIVE FREE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Merck | PEPCID PRESERVATIVE FREE | famotidine | INJECTABLE;INJECTION | 019510-004 | Nov 4, 1986 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Merck Sharp Dohme | PEPCID PRESERVATIVE FREE IN PLASTIC CONTAINER | famotidine | INJECTABLE;INJECTION | 020249-001 | Feb 18, 1994 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for PEPCID PRESERVATIVE FREE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Merck | PEPCID PRESERVATIVE FREE | famotidine | INJECTABLE;INJECTION | 019510-004 | Nov 4, 1986 | ⤷ Try a Trial | ⤷ Try a Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for PEPCID PRESERVATIVE FREE
See the table below for patents covering PEPCID PRESERVATIVE FREE around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Finland | 70890 | ⤷ Try a Trial | |
| Spain | 487381 | ⤷ Try a Trial | |
| Germany | 3008056 | ⤷ Try a Trial | |
| Netherlands | 930038 | ⤷ Try a Trial | |
| Japan | S55118476 | NOVEL AMIDINE DERIVATIVE AND ITS PREPARATION | ⤷ Try a Trial |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
